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Abstract 56 
Workshops are an important part of the IFPA annual meeting as they allow for discussion of 57 
specialised topics.  At IFPA meeting 2016 there were twelve themed workshops, four of which 58 
are summarized in this report.  These workshops related to various aspects of placental biology 59 
but collectively covered areas of decidual-trophoblast interaction, regulation of trophoblast 60 
invasion, immune cells at the maternal-fetal interface, and placental inflammation.  61 
 62 
Keywords: decidua; trophoblast; uterine natural killer cells; macrophages; Zika virus; P. 63 
gingivalis; placenta; inflammation; invasion 64 
  65 
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Decidua-Trophoblast Interactions 66 
Organizer: Gendie Lash 67 
Speakers: Sonia DaSilva-Arnold, Christina Duzyj, Gendie Lash, Peggy Petroff 68 
Outline: Invasion of the uterine decidua and inner third of the myometrium by extravillous 69 
trophoblast cells (EVT) and the associated remodeling of the spiral arteries are key to the 70 
establishment of a healthy successful pregnancy.  During these processes EVT interact with 71 
different decidual cell types including decidual stromal cells, uterine natural killer cells, uterine 72 
macrophages, different T cell populations, vascular smooth muscle cells, endothelial cells and 73 
myometrial cells.  These interactions have the potential to alter the phenotype, and therefore 74 
function, of either interacting cell type.  The aim of this workshop is to explore some of these 75 
interactions and discuss how they contribute to the establishment of a healthy pregnancy. 76 
Summary: Peggy Petroff discussed the potential mechanisms of communication between 77 
decidual cell populations and trophoblast.  Extracellular vesicles, which include exosomes and 78 
larger microvesicles, are now recognized as a conserved form of intercellular communication.  79 
From the earliest stages of development, the embryo and later, the placenta secrete copious 80 
quantities of vesicles.  These vesicles are likely to influence key processes in implantation, 81 
placentation, and maternal-fetal interactions – including those between trophoblast cells and 82 
maternal immune cells.  Ongoing work is defining these interactions; technological advances 83 
will play key roles in determining the nature and importance of vesicular communication 84 
between the mother and the fetus.  Likely roles for extracellular vesicles include 85 
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decidualization, intra-embryonic communication, and establishment of maternal tolerance to 86 
the fetus, potentially through modification of maternal antigen presenting cells. 87 
 88 
Gendie Lash presented data on the consequences of decidual leucocyte (uterine natural killer 89 
(uNK) cell) and EVT communication.  In the placental bed uNK cells are a major source of 90 
cytokines and angiogenic growth factors (AGFs) with AGF levels decreasing and cytokine levels 91 
increasing with gestational age.  The factors that regulate AGF and cytokine secretion are 92 
unclear but may involve interactions between uNK cells and EVT.  Co-culture of uNK cells and 93 
EVT resulted in a reduction in levels of several AGFs and cytokines.  Interestingly, AGF levels 94 
were reduced under both direct and indirect co-culture conditions while cytokines were only 95 
reduced after direct contact.  Local production of AGFs and cytokines in the placental bed are 96 
likely lowered when uNK cells come in direct contact with EVT, via a mechanism potentially not 97 
mediated by HLA. 98 
 99 
Christina Duzyj discussed multinuclear trophoblast giant cells and evidence that there is 100 
ongoing terminal differentiation of EVT throughout gestation.  The duration of uterine invasion 101 
by EVT has been a subject of debate.  Although older literature supports the notion that 102 
invasion stops by mid-pregnancy, newer data contests this paradigm.  The molecular signals 103 
that alter the invasive EVT phenotype to limit the depth of invasion to the inner third of the 104 
myometrium during pregnancy, and the eventual endpoint of EVT maturation are not 105 
understood.  It was proposed that reversal of epithelial to mesenchymal EVT transition, and 106 
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fusion of mononuclear interstitial EVT into multinucleated giant cells represents completion of 107 
the life course of EVT.  It was suggested this fusion is a process which involves multiple stages, 108 
continues to term and is as yet poorly understood. 109 
 110 
Sonia DaSilva-Arnold discussed how there may be a disconnection between EVT genotype and 111 
phenotype in abnormally invasive placenta.  There is a need to acknowledge the role of the 112 
decidua in abnormally invasive placenta, particularly since alterations in decidual cell 113 
populations have been shown to result in abnormally invasive placentae.  Specifically, there is 114 
evidence that the loss of uterine natural killer cells may contribute to trophoblast over-invasion 115 
pathologies.  There is also evidence that both phenotypic and genotypic changes characteristic 116 
of epithelial-mesenchymal transition occur in the differentiation of cytotrophoblast to 117 
extravillous trophoblast.  118 
Conclusions:  The decidua (comprised of a complex mix of leucocytes, stromal cells, blood 119 
vessels and glandular epithelial cells) has the ability to modulate trophoblast cell phenotype 120 
and behavior.  In addition, EVT are also able to modulate the phenotype and behavior of 121 
different cell types within the decidua, the best studied being the different leucocyte 122 
populations, endothelial cells and vascular smooth muscle cells.  The exact mechanisms of 123 
these different interactions is not known but likely involves secreted ligands interacting with 124 
cell surface receptors, direct cell-cell interactions, as well as cellular communication via 125 
exosomes or microparticles.  These complex interactions are required to facilitate invasion of 126 
the EVT to an appropriate depth as well as remodeling of the uterine spiral arteries.  Any 127 
disturbances in the balance of interactions would lead to aberrant invasion and remodeling, 128 
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leading to major obstetric complications such as pre-eclampsia, fetal growth restriction, late 129 
miscarriage, placenta accreta etc.  This workshop highlighted some of the potential 130 
mechanisms of decidua-EVT interactions as well as the consequences of these interactions for 131 
EVT as well as some decidual cell sub-populations.  It also highlighted that the majority of 132 
research to date has focused on regulation of EVT invasion and there are many other EVT traits 133 
that we know little about.  The workshop stimulated lively discussion on some of these under 134 
studied areas of EVT biology. 135 
 136 
 137 
Key mechanisms and novel insights into trophoblast implantation and invasion 138 
Organizers: Martin Knöfler, Alexander Beristain 139 
Speakers: John Aplin, Alexander Beristain, Caroline Dunk, Jürgen Pollheimer, Michael Soares  140 
Outline: Trophoblast differentiation along the invasive pathway is fundamental to early 141 
implantation, placental development and establishment of the fetal-maternal interface.  142 
Multiple gene pathways and heterogeneous cellular interactions have been described in 143 
directing and controlling trophoblast invasion.  The focus of this workshop aimed to address 144 
well accepted as well as controversial paradigms central to the intrinsic control of trophoblast 145 
invasion.  Novel cellular mechanisms with respect to implantation, development of an early 146 
invasive trophoblast lineage, and new insights into the versatile functions of invasive 147 
trophoblasts were discussed.  The importance of key transcription factors, the cell cycle and 148 
aging as well as the role of polyploidy and ADAM proteases in differentiating extravillous 149 
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trophoblast populations was a primary focus.  Moreover, the role of external environmental 150 
stimuli, such as hypoxia and mechanisms regulating EVT-uterine leucocyte cross-talk were 151 
explored. 152 
 153 
Summary: John Aplin discussed the development of the invasive trophoblast phenotype in the 154 
early stages of implantation.  In early pregnancy, maternal and embryonic signals prime the 155 
receptivity of the uterine luminal epithelium (LE) before the trophectoderm (TE) of the 156 
blastocyst-stage embryo mediates attachment.  It was hypothesised that receptivity requires an 157 
active maternal juxtacrine signal to initiate trophoblast differentiation.  Using in vitro cell 158 
culture methods it was shown that mouse or human blastocysts or BeWo cell spheroids stably 159 
attached to confluent human endometrial epithelial Ishikawa cells, followed by breaching and 160 
trophoblast outgrowth.  Day 6 human blastocysts readily attached to the Ishikawa cell layers 161 
and co-culture for 48 hours demonstrated an onset of GATA3, HLAG and hCG expression.  This 162 
novel model to investigate early trophoblast differentiation implicates primary syncytium as the 163 
pioneer invasive cell type in human embryo implantation, and giant cells in mouse.  Interaction 164 
with the receptive epithelium initiates trophoblast differentiation and the onset of appearance 165 
of invasive behaviour. These findings have clinical implications for assisted reproductive 166 
technologies as well as biological importance in understanding early placentation. 167 
 168 
Michael Soares discussed plasticity in development of the invasive trophoblast lineage.  169 
Hemochorial placentation involves orchestrated temporal and spatial decisions governing the 170 
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fate of trophoblast stem/progenitor cells.  Trophoblast cell acquisition of specializations 171 
facilitating invasion and uterine spiral artery remodeling is a labile process, sensitive to the 172 
environment, and a process that is vulnerable to dysmorphogenesis in pathologic states.  The 173 
rat exhibits deep intrauterine trophoblast invasion and is an experimentally tractable model for 174 
investigating mechanisms controlling trophoblast-directed changes in the uterine vasculature.  175 
Hypoxia can be used as a tool to elucidate acquisition of the invasive trophoblast phenotype.  176 
Placental adaptations to environmental challenges highlight the importance of plasticity in 177 
safeguarding a healthy pregnancy. 178 
 179 
Jürgen Pollheimer presented an overview of the versatile functions of invasive EVT.  These 180 
include: plugging of spiral arteries, interaction with immune cells, defense against pathogens, 181 
disruption of the arterial smooth muscle layer, and invasion into arteries and glands.  182 
Furthermore, novel evidence that human EVT actively secrete factors into the maternal 183 
circulation ensuring maternal adaption to pregnancy was discussed.  Data were presented 184 
showing that an EVT-specific factor is detectable in serum of pregnant women from 7-8 weeks 185 
of gestation.  It was postulated that the EVT secretome may serve as an early predictive marker 186 
for complicated pregnancies.    187 
 188 
Alexander Beristain discussed the role of ADAM proteases in trophoblast differentiation and 189 
how they may be involved in establishing protective mechanisms under hypoxia.  Trophoblast 190 
cells differentiating along the invasive pathway regulate the expression of diverse subtypes of 191 
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proteases.  Invasive EVT express a specific repertoire of ADAM proteases, however the 192 
regulation and function of ADAMs in trophoblast biology is poorly understood.  Global 193 
transcriptomic studies performed by various groups, supported by targeted ex vivo expression 194 
studies using purified subtypes of trophoblasts, have provided needed insight into their 195 
functions in early placentation.  Moreover, the importance of oxygen levels has also provided 196 
insights into regulatory mechanisms controlling ADAM expression and function in invasive 197 
trophoblast subtypes, where low and high oxygen environments differentially regulate multiple 198 
subtypes of ADAM proteases.  199 
 200 
Caroline Dunk presented recent work investigating the impact of the Y153H SNP in STOX1 201 
transcription factor mediated effects on EVT-leukocyte interactions. It has been previously 202 
shown that the maternal decidual uNK cells and macrophages play a crucial role in the early 203 
disruption and transformation of the uterine spiral arteries.  It has been hypothesised that 204 
there is a chemokine mediated communication between the EVT, vasculature and maternal 205 
leukocytes.  Placental explants carrying the STOX1 Y153H mutant TF have smaller EVT 206 
outgrowths, secrete lower levels of the chemokines IL-6, IL-8, CCL-2, CXCL1, CX3CL1 and 207 
sEndoglin, while upregulating CXCL16 and Angiopoietin-2.  Invasion assays showed that in 208 
comparison to wild type, Y153H STOX EVT conditioned media (Y153H CM) did not stimulate 209 
uNK invasion.  Monocytes underwent apoptosis in Y153HH CM.  It was also shown that Y153H 210 
mutant STOX1 expression was increased in severe early onset pre-eclamptic and preterm 211 
placenta as compared to late onset pre-eclampsia or term controls, however 60% of placentas 212 
do not carry the mutation thus it is not the only factor contributing to the pathogenesis of early 213 
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onset pre-eclampsia.  Preliminary data were presented showing the incidence of the GG 214 
mutation of the rs1425954 SNP in the ACVR2A promoter.  This SNP is specifically enriched in 215 
early onset pre-eclamptic placentas with a small for gestational age baby, both STOX and 216 
ACVR2A SNPs were found in 7/9 of this group. In conclusion, it has been shown that EVT 217 
carrying the STOX1 have an altered secretome and do not support uNK cell or monocyte 218 
invasion, and thus may contribute to the failure of uterine vascular remodeling observed in 219 
pathological placentation. 220 
 221 
Conclusions: Complex interactions between trophoblasts and different uterine/decidual cell 222 
populations as well as environmental conditions critically regulate implantation, trophoblast 223 
invasion, and uterine vessel remodeling. An intrinsic molecular program dictates 224 
EVT/trophoblast function and differentiation, but these processes are also likely controlled by 225 
the decidual environment and its cell types. Vice versa, uterine leukocytes are affected by the 226 
EVT-specific secretome and cell-cell contacts with EVT. 227 
 228 
 229 
Immunology at the Maternal-Fetal Interface 230 
Chairs: Margaret Petroff, Thaddeus Golos 231 
Speakers: Caroline Dunk, Thaddeus Golos, Ulrike Kemmerling, Gendie Lash, Leticia Reyes, 232 
Jennifer Stencel-Baerenwald 233 
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Outline: Immune cells at the maternal-fetal interface can serve multiple purposes.  On the one 234 
hand, they play an important role in placental development and uterine remodeling; on the 235 
other, they participate in defense against pathogens and prevent vertical transmission.  Yet a 236 
third effect is the ‘bystander’ damage that occurs as a result of inflammation when infection or 237 
other stressors are present.  In this workshop these seeming Janus-faced roles of immune and 238 
other cells, and immune-mediated processes that occur in normal pregnancy were discussed.  239 
Topics to be discussed included the involvement of immune cells in normal processes involved 240 
in placentation such as trophoblast invasion and spiral artery remodeling; phenotypic changes 241 
that occur in immune cells as a result of infection; and how trophoblast cells themselves 242 
respond to, and may protect against different types of infection.  Furthermore, with the recent, 243 
alarming rise in transmission and teratogenic effects of Zika virus infections, two discussants 244 
illuminated novel models of primate Zika infection. 245 
 246 
Summary: Caroline Dunk presented a global analysis of decidual immune cell populations 247 
demonstrating dynamic changes with gestation between 6 and 20 weeks, focusing in detail on 248 
uNK cell and neutrophil populations.  Uterine NK cells remain constant in number (70-80%) but 249 
increasing numbers express CD314/NKG2D and Nkp80 receptors on their surface.  Despite this, 250 
2
nd
 trimester uNK cells are less able to mount a cytotoxic response as measured by PMA-251 
stimulated perforin release.  Direct interaction with the HTR-8/SVneo trophoblast-like cell line 252 
decreased CD314 expression and uNK cell viability, while HTR-8/SVneo secreted factors 253 
decreased both IFNγ and perforin release.  CD3
+
CD4
+
 T cells increase with gestation while 254 
monocytes decrease in number and differentiate to an M2c phenotype expressing both CD163 255 
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and CD206.  Immature CD209
+
 dendritic cells are high in the 1
st
 trimester, numbers decrease 256 
and do not differentiate into mature CD81
+
 antigen presenting cells.  Recent data identifying a 257 
novel angiogenic neutrophil population similar to N2 neutrophils that is resident in 2
nd
 258 
trimester decidua basalis was also presented.  Investigation of the decidual effect on normal 259 
healthy and pre-eclamptic peripheral blood neutrophils showed significant changes in mRNA 260 
expression of several known N1/N2 factors of which 3 can reliably distinguish pre-eclampsia 261 
from 26 week samples.  It was concluded that healthy pregnancy is characterised by adaption 262 
of the decidual immune cells to a pro-angiogenic, tissue remodeling, adaptive phenotype.  263 
Resistance of the maternal immune cells to decidual differentiation may contribute to the 264 
inflammatory endothelial dysfunction and deficient uterovascular remodeling associated with 265 
pre-eclampsia. 266 
 267 
Gendie Lash discussed the potential role of decidual macrophages in remodeling of the uterine 268 
spiral arteries.  Incomplete spiral artery remodeling is associated with the pathogenesis of a 269 
number of complications of pregnancy including late miscarriage, pre-eclampsia and fetal 270 
growth restriction.  Despite the importance of spiral artery remodeling in the establishment of 271 
a successful pregnancy, little is known about the molecular triggers for this complex process 272 
that appears to require the co-ordinated activity of a number of cell types including uNK cells, 273 
macrophages, EVT and vascular smooth muscle cells.  Data were presented showing that 274 
decidual macrophages secrete a wide range of cytokines, angiogenic growth factors and matrix 275 
metalloproteinases.  However, unlike uNK cells, they do not induce vascular smooth muscle cell 276 
morphological changes or de-differentiation.  They are able to facilitate breakdown of the 277 
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vascular extracellular matrix, but this is not sufficient to induce vascular smooth muscle cell 278 
separation and morphological change.  Their most important role is likely in the phagocytosis of 279 
apoptotic vascular smooth muscle cell to allow their clearance from the vessel wall.  It was 280 
postulated that in situations of infection or inflammation the decidual leucocytes are not able 281 
to perform their tissue remodeling roles, therefore contributing to the aetiology of 282 
complications of pregnancy. 283 
 284 
Ulrike Kemmerling spoke about trophoblast epithelial turnover (particularly the role of caspase 285 
8) as an innate defense mechanisms against T. Cruzi, but not against T. gondii.  Data were 286 
presented showing that the parasites activate different TLRs in human placental chorionic villi 287 
explants leading to differential cytokine/chemokine profiles.  These data might explain, at least 288 
partially, differential susceptibility of the placenta to the infection of both parasites. 289 
 290 
Leticia Reyes discussed links between periodontal disease and adverse outcomes of pregnancy.  291 
Porphyromonas gingivalis (Pg), a keystone species of periodontal disease, has been implicated 292 
in preterm delivery.  The presence of Pg within the placental villous mesenchyme is linked to 293 
shorter gestational age in pregnancies with histologic chorioamnionitis, chorioamnionitis with 294 
funisitis, pre-eclampsia and pre-eclampsia with HELLP-syndrome. Since Pg subverts host 295 
antimicrobial defenses, it was postulated that infection of the placental stroma perturbs the 296 
activation state of fetal macrophages.  The co-localization of macrophage markers was 297 
measured: anti-inflammatory CD163 and pro-inflammatory CD68 in preterm specimens 298 
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matched by gestational age and complication.  It was that found Pg positive placentas had 299 
decreased CD68+/CD163 ratios suggesting a shift towards an anti-inflammatory profile.  300 
 301 
Jennifer Stencel-Baerenwald discussed Zika virus (ZIKV) as a neuroteratogenic pathogen and the 302 
need for animal models that can be used to test vaccines and antiviral drugs.  Data were 303 
presented demonstrating vertical transmission of ZIKV in a non-human primate model of 304 
infection using M. nemestrina.  Viral load was detected in fetal organs including the brain and 305 
placenta.  Moreover, periventricular lesions and white matter hypoplasia were observed in the 306 
fetal brain using serial magnetic resonance imaging.  Collectively, these findings enhance our 307 
understanding of transplacental ZIKV trafficking and provide the basis for a novel ZIKV model 308 
for therapeutic intervention. 309 
 310 
Thaddeus Golos continued the discussion on Zika virus.  Maternal infection with Zika virus has 311 
been correlated in Brazil with fetal microcephaly, however questions remain regarding 312 
maternal susceptibility, rates of fetal infection, and risk factors such as co-infection.  A rhesus 313 
macaque model has been developed demonstrating consistent susceptibility to Zika but rapid 314 
(within 10 days) clearance in nonpregnant individuals.  As seen in pregnant women, prolonged 315 
maternal viremia (up to 10 weeks) was observed in pregnant monkeys, and only sporadic fetal 316 
viral RNA was detected within individual pregnancies; however all pregnancies had detectable 317 
viral burden and fetal inflammatory pathology; thus 100% maternal-fetal transmission was 318 
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noted.  The macaque model will allow investigation of maternal and environmental factors 319 
influencing transmission to the fetus, and development of strategies to interrupt fetal infection.  320 
 321 
Conclusions:  Immune cells and trophoblast cells have dual roles in pregnancy, which include 322 
both establishment of normal placentation and protection when the maternal-fetal interface is 323 
threatened with infection.  Macrophages and uterine NK cells are understood now to play 324 
distinct molecular roles in placentation, which may be perturbed in the setting of infection-325 
induced inflammation and in defective placental developmental processes such as that in 326 
preeclampsia.  Ongoing work continues to identify novel cell types that may be entirely unique 327 
to the maternal fetal interface, and it will be particularly important to identify the roles these 328 
cells play in normal and abnormal pregnancy.  Finally, the rapid response of the biomedical 329 
research community in development of new, highly relevant models of clinical infection is 330 
critical for our ability to respond to future emerging pathogens that endanger maternal and 331 
fetal health. 332 
 333 
 334 
Inflammation – What is it and how does it affect the placenta 335 
Chairs: Murray Mitchell, Kent Thornburg 336 
Speakers: Murray Mitchell, David Olson, Pepper Schedin, Kent Thornburg 337 
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Outline: Inflammation or mediators of inflammation play important roles in many physiological 338 
and pathological mechanisms in reproductive biology.  The relationships between pathogen-339 
driven inflammation versus non-infectious inflammation or more simply, ‘hot’ versus ‘cold’ 340 
inflammation are complex.  The different intracellular pathways that are activated in chronic 341 
versus acute processes are important and not understood even though they should result in 342 
different approaches to therapy.  This workshop was designed to discuss these two types of 343 
inflammation and how they apply to the human placenta with the hope that the field can 344 
develop a more appropriate nomenclature for describing the inflammatory processes.  345 
 346 
Summary: Kent Thornburg introduced the concepts of ‘hot’ and ‘cold’ inflammation. According 347 
to the Britannica Encyclopedia Pathology, the definition of inflammation is the response to 348 
tissue damage that “… consists of changes in blood flow, an increase in permeability of blood 349 
vessels, and the migration of fluid, proteins, and white blood cells (leukocytes) from the 350 
circulation to the site of tissue damage.”  This is the classical scenario of so-called “hot-351 
inflammation.”  However, it is becoming increasingly clear that another form of inflammation 352 
can occur with many of the same cell signaling events and gene expression patterns as in hot 353 
inflammation but without leukocyte infiltration and fluid extravasation.  This has become 354 
known as “cold inflammation” or “metinflammation”; this condition may become a chronic 355 
state that harms tissues through increasing levels of oxidative stress and detrimental cytokines.   356 
 357 
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Murray Mitchell discussed how inflammation or mediators of inflammation play important 358 
roles in many physiological and pathological mechanisms including: asthma, diabetes, heart 359 
diseases, obesity, certain cancers, depression, dementia and rheumatoid arthritis.  360 
“Inflammation” during pregnancy is thought to result in increased risk of disorders including 361 
childhood leukemia.  The relationships between pathogen-driven inflammation versus non-362 
infectious inflammation are complex.  Nature has utilised inflammatory mediators, notably 363 
cytokines, in physiological mechanisms as well as in acute responses to stimuli.  Hence sterile 364 
inflammation, cold inflammation and metinflammation are physiological mechanisms, for 365 
example used for parturition.  366 
 367 
David Olson discussed the great confusion regarding naturally occurring inflammatory events 368 
and infection in birth at term and preterm.  There is confusion over the roles of inflammation 369 
vis-à-vis infection (chorioamnionitis) in the ontogeny of birth at term and especially at preterm.  370 
This can lead to an over-diagnosis of chorioamnionitis and an unnecessary number of cesarean 371 
sections with their associated risks.  Both the non-infectious inflammatory processes (termed 372 
‘cold’ or ‘sterile’ inflammation) and infectious processes (termed ‘hot’ inflammation) involved 373 
with preterm birth were discussed.  In addition, the adverse effects of infection upon the fetus 374 
were described.  Methods used to diagnose and define histologic chorioamnionitis and 375 
infectious chorioamnionitis were also discussed and new tools for mitigating the effects of 376 
infection considered. 377 
 378 
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Pepper Schedin discussed inflammation at epithelial cell barriers.  The immune system, once 379 
thought to be an independent monitor of tissue injury and initiator of tissue repair, is 380 
increasingly appreciated for its integrated roles in normal tissue biology.  For example, the 381 
study of mucosal biology, or how an organ exposed to the outside environment is protected 382 
from foreign antigens, has identified immune cell functions that shed light on basic epithelial 383 
cell decisions including proliferation, differentiation, death, and immune avoidance.  Thus it is 384 
not surprising that dysregulated immune function contributes to numerous epithelial 385 
pathologies ranging from solid cancers to premature births.  At this point in time, a wealth of 386 
knowledge has been obtained regarding the complex, and at times seemingly disparate roles of 387 
hot (Th1-skewed) and cold (Th2 and/or Th17 skewed) inflammation in mucosal biology and 388 
cancer.  Cross fertilization between these fields is poised to significantly advance our 389 
understanding of placental biology and positively impact human pregnancies.  However, 390 
because the immune system is intimately involved in numerous aspects of placental biology, 391 
that path forward will have its share of surprises, unbiased high quality data will be of the 392 
essence.  As a potential new practitioner of immune biology, it will be necessary to understand 393 
the inherent yin yang of the immune system, which is always under balance and counter 394 
balance influences in an effort to maximally ward off external threats while minimizing damage 395 
to self.  The key to moving forward is to embrace the complexity of immune data without 396 
preconceived ideas as to what immune cells or functions constitute a ‘good’ or ‘bad’ immune 397 
milieu within the placenta.  398 
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Conclusions: With vigorous audience participation, there was agreement that 1) hot and cold 400 
inflammation are important processes in normal and pathological pregnancies and that 2) there 401 
is a need for better terminology in defining inflammation in the placenta.  The many apparent 402 
roles of the immune system in pregnancy have not been well defined.  Thus, there is an urgent 403 
need for research to clarify roles of hot and cold inflammatory processes in placentation and in 404 
placental function as pregnancy progresses.  The group suggested that a working group be 405 
formed to develop a white paper on the topic. 406 
 407 
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